Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03803683 · ClinicalTrials.gov registry record · NA

Improving Health Outcomes in Young Cisgender Men and Transgender Women (mLab App)

A NA study of HIV Infections, sponsored by Rebecca Schnall, RN, MPH, PhD.

Completed
Registry status
NA
Development phase
525
Enrollment target
2
Study locations

NCT03803683: Completed NA study of HIV Infections, sponsored by Rebecca Schnall, RN, MPH, PhD.

NCT03803683 is a NA study of HIV Infections that has completed, run by Rebecca Schnall, RN, MPH, PhD. The registered enrollment target is 525 participants, above the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (18% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03803683, a NA study of HIV Infections, has completed, sponsored by Rebecca Schnall, RN, MPH, PhD.

COMPLETED
Registry status
NA
Development phase
525 participants
Enrollment target
2
Study locations

Study Summary

The mLab App combines HIV prevention information with push notifications/reminders to complete HIV testing and an automated image processing feature to provide real-time feedback on home-based HIV test results. Theoretically-guided by the Health Information Technology Usability Evaluation Model (Health-ITUEM), the proposed project will refine and test a next-generation diagnostic intervention delivered on a mobile platform to improve HIV testing and linkage-to-care outcomes among youth living with and at-risk for HIV. Given the pervasiveness, low cost, and convenience of mobile technology, the investigators hope that the App can help achieve the goals of the National HIV/AIDS Strategy in the US by increasing the number of persons living with HIV who know their serostatus, decreasing HIV-related disparities, and ultimately reducing the risk of HIV transmission and acquisition.

Conditions Studied

HIV Infections

Interventions

  • DEVICE mLab App
  • BEHAVIORAL HIV Prevention Information
  • DEVICE HIV Home Tests

Study Locations (2)

Illinois

  • Lurie Children's Hospital - Chicago

New York

  • Columbia University School of Nursing - New York

Trial Details

FieldValue
Enrollment Target 525 participants
Start Date 2020-01-21
Est. Completion 2023-10-02
Phase NA

Sponsor

Rebecca Schnall, RN, MPH, PhD

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03803683

The ClinicalTrials.gov registry entry for NCT03803683 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 525 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (18% higher). The listed sponsor is Rebecca Schnall, RN, MPH, PhD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 3 interventions - of which mLab App is the first listed.

NCT03803683 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, New York.

Frequently Asked Questions

What is clinical trial NCT03803683 about?

NCT03803683 is a clinical study titled "Improving Health Outcomes in Young Cisgender Men and Transgender Women (mLab App)". The mLab App combines HIV prevention information with push notifications/reminders to complete HIV testing and an automated image processing feature to provide real-time feedback on home-based HIV test results. Theoretically-guided by the Health Information Technology Usability Evaluation Model (Hea...

What is the current status of trial NCT03803683?

This trial is currently completed. It is a NA study. The enrollment target is 525 participants. The study started on 2020-01-21. Estimated completion is 2023-10-02.

What conditions does trial NCT03803683 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT03803683?

The interventions under investigation include: mLab App (DEVICE), HIV Prevention Information (BEHAVIORAL), HIV Home Tests (DEVICE).

Who is sponsoring clinical trial NCT03803683?

This trial is sponsored by Rebecca Schnall, RN, MPH, PhD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03803683 being conducted?

This trial has 2 study locations across Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.